Topics
トピックス
- Our patent for an animal model of Alzheimer’s disease has been registered.
- Our patent on drdrebrin-binding peptide was registered.
- Our patent for a diagnostic agent has been registered.
- We have been selected for the Tokyo Metropolitan Small and Medium Enterprise Promotion Agency’s startup intellectual property support program.
- Presenting as the Japanese representative at the world’s largest startup competition, the Extreme Tech Challenge (XTC) World Finals
- Presented as a finalist at the MedTech Grand Prix Kobe 2021 and received the First Life Holdings Award.
- The CEO Shirao contributed to a paper on primary cilia in Alzheimer’s disease neurons, which has been published in the international journal ‘Biochemical and Biophysical Research Communications (BBRC).
- Representing Japan, the entrepreneur aiming for global impact in addressing international challenges will be speaking at the world’s largest startup competition, the Extreme Tech Challenge (XTC) World Finals.